Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.190
+0.240 (8.14%)
At close: Dec 20, 2024, 4:00 PM
3.400
+0.210 (6.58%)
After-hours: Dec 20, 2024, 6:17 PM EST
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 15 or -93.75% compared to the previous year.
Employees
1
Change (1Y)
-15
Growth (1Y)
-93.75%
Revenue / Employee
$194,000
Profits / Employee
-$5,281,000
Market Cap
8.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Meihua International Medical Technologies | 617 |
XWELL | 337 |
Mustang Bio | 80 |
RedHill Biopharma | 53 |
Viracta Therapeutics | 40 |
Dominari Holdings | 28 |
NeuroMetrix | 26 |
Elevai Labs | 18 |
CYCN News
- 4 days ago - Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewsWire
- 4 months ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 1 year ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 1 year ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 1 year ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 1 year ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Cyclerion Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - GlobeNewsWire